Cargando…
Blood and urine biomarkers in osteoarthritis – an update on cartilage associated type II collagen and aggrecan markers
Osteoarthritis (OA) is a painful disease for which drug development has proven difficult. One major reason for this is the heterogeneity of the disease and the current lack of operationalized means to distinguish various disease endotypes (molecular subtypes). Biomarkers measured in blood or urine,...
Autores principales: | Bay-Jensen, Anne C., Mobasheri, Ali, Thudium, Christian S., Kraus, Virginia B., Karsdal, Morten A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635261/ https://www.ncbi.nlm.nih.gov/pubmed/34652292 http://dx.doi.org/10.1097/BOR.0000000000000845 |
Ejemplares similares
-
Ribosome dysfunction in osteoarthritis
por: van den Akker, Guus G.H., et al.
Publicado: (2022) -
Recent developments in emerging therapeutic targets of osteoarthritis
por: Sun, Margaret Man-Ger, et al.
Publicado: (2017) -
The gut microbiome-joint connection: implications in osteoarthritis
por: Favazzo, Lacey J., et al.
Publicado: (2020) -
Insights into the molecular landscape of osteoarthritis in human tissues
por: Katsoula, Georgia, et al.
Publicado: (2022) -
Thickness of the bone-cartilage unit in relation to osteoarthritis severity in the human hip joint
por: Hartlev, Louise Brøndt, et al.
Publicado: (2018)